Saturday, February 8, 2025

CATEGORY

Pharmacoeconomics

Cost-Benefit Analysis Reveals Optimal Melanoma Therapies in Netherlands

A recent study conducted in the Netherlands scrutinizes the economic viability of various treatment sequences for patients battling advanced melanoma with a BRAF mutation....

Cost and Effectiveness of PrEP Programs Vary Across South Africa

South Africa's initiatives to provide daily oral pre-exposure prophylaxis (PrEP) for HIV prevention reveal significant differences in both costs and effectiveness across various communities....

EAM System Slashes Radiation in Heart Procedures, Increases Healthcare Costs

The adoption of Electro-anatomical Mapping (EAM) systems presents a promising alternative to traditional fluoroscopy for conducting Conduction System Pacing (CSP) in patients suffering from...

Catch-Up HPV Vaccination in Czech Republic Proves Cost-Effective, Saves Lives

A recent study highlights the significant health and economic benefits of implementing a catch-up human papillomavirus (HPV) vaccination program for individuals aged 15-21 in...

Economic Models in Pediatric Diabetes Fail to Mirror Clinical Guidelines

Recent research highlights significant discrepancies between economic models used for pediatric diabetes and established clinical guidelines, raising concerns about their effectiveness in guiding healthcare...

Italian Drug Labels Highlight Gaps in Genetic Testing Recommendations

Italian regulatory authorities have undertaken a comprehensive review of pharmacogenetic information within the summaries of product characteristics (SmCPs) for approved medications. This analysis aims...

Fosnetupitant Tops Cost-Effectiveness in Japanese Study on Chemotherapy Nausea Prevention

A recent study conducted in Japan has determined that fosnetupitant (F-NTP) offers a more cost-effective solution compared to fosaprepitant (F-APR) in preventing chemotherapy-induced nausea...

ACT NOW Initiative Reduces Breast Cancer Mortality and Financial Strain in Philippines

The Philippines has introduced ACT NOW, an innovative pilot program aimed at guiding women through complimentary early breast cancer detection and subsequent treatment. Targeting...

Burkina Faso Leverages Economic Model to Prioritize Vitamin A Intervention Programs

Addressing vitamin A deficiency among young children in Burkina Faso remains a critical public health challenge. Recent efforts focus on strategic planning to identify...

Economic Forces Drive Antibiotic Use in Australia, Study Finds

Antimicrobial resistance (AMR) continues to pose a significant threat to global health, with antibiotic usage playing a critical role in its escalation. A recent...

Delays in PCV20 Rollout Cost Health and Economy, Study Shows

Recent research reveals that postponing the adoption of the 20-valent pneumococcal conjugate vaccine (PCV20) in pediatric immunization programs has resulted in significant public health...

Philippines’ ACT NOW Initiative Reduces Breast Cancer Deaths and Financial Strain

The Philippines is making significant strides in combating breast cancer through the ACT NOW program, which offers free early detection and treatment services to...

ACT NOW Initiative Cuts Breast Cancer Deaths and Shields Filipino Women from Financial Ruin

The Philippines is taking significant strides in combating breast cancer through the ACT NOW program, a pioneering effort that guides women from early detection...

QALY Metrics Steady in Cancer Drug Evaluations with Minimal Subgroup Focus

Recent analysis underscores the steadfast role of quality-adjusted life-year (QALY) in assessing cancer treatments, revealing limited attention to patient subgroups in cost-effectiveness studies. Comprehensive Review...

Combined Strategies Effectively Control HBV and HIV Co-Infection Spread, Study Finds

A recent study highlights the significant impact of implementing targeted protection and treatment strategies to curb the dual spread of Hepatitis B virus (HBV)...

Latest news